Basic Information
LncRNA/CircRNA Name | SNHG12 |
Synonyms | NA |
Region | GRCh38_1:28578538-28582983 |
Ensemble | ENSG00000197989 |
Refseq | NR_024127 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | qPCR, Luciferase reporter assay |
Sample | Normal intestinal epithelial NCM460 cells and CRC cell lines, including HT-29, SW480, SW620 and LOVO, CRC tissues and their matched adjacent non-tumour tissues |
Expression Pattern | up-regulated |
Function Description | SNHG12 was markedly upregulated in CRC tissues when compared with that in adjacent non-tumour tissues, and its high expression was associated with CRC progression, as well as poor prognosis of patients. In addition, the expression of SNHG12 was higher in CRC cell lines when compared with that in a normal intestinal epithelial cell line. Knockdown of SNHG12 significantly inhibited CRC cell proliferation and invasion, while ectopic overexpression of SNHG12 had the opposite effect. A Bioinformatics analysis predicted that SNHG12 and miR-16 have complementary binding sites, which was confirmed by a luciferase reporter gene assay. The expression levels of miR-16 were markedly decreased in CRC tissues and cell lines compared with those in normal tissues or cells, and were inversely correlated with the expression levels of SNHG12 in CRC tissues. Furthermore, silencing of miR-16 eliminated the suppressive effects of SNHG12 knockdown on CRC cell proliferation and invasion. |
Pubmed ID | 31316616 |
Year | 2019 |
Title | Long non-coding RNA SNHG12 promotes proliferation and invasion of colorectal cancer cells by acting as a molecular sponge of microRNA-16 |
External Links
Links for SNHG12 | GenBank HGNC NONCODE |
Links for colorectal cancer | OMIM COSMIC |